SCHEMBL1011353

SCHEMBL1011353

COc1ccccc1Oc1cnc(-c2ncc(Cl)c(Cl)n2)nc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
DHPS P49366 13/20 0.45
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
POLB P06746 1/20 0.41
PIN1 Q13526 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PPP1CA P62136 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7700406 0.78 LMNA (0.50) LMNAL3MBTL1ALDH1A1HTTDHPS
SCHEMBL1011352 0.72 LMNA (0.44) LMNAL3MBTL1ALDH1A1DHPSMEN1
SCHEMBL11544969 0.72 L3MBTL1 (0.60) L3MBTL1ALDH1A1MAPK1HTTDHPS
SCHEMBL618135 0.72 DHPS (0.58) DHPS
SCHEMBL29770374 0.72 DHPS (0.58) DHPS
SCHEMBL9423908 0.69 LMNA (0.55) LMNAL3MBTL1ALDH1A1DHPSMEN1
SCHEMBL3236824 0.69 METAP1 (0.34) LMNAL3MBTL1ALDH1A1POLB
SCHEMBL1443043 0.68 LMNA (0.44) LMNAL3MBTL1ALDH1A1HTTMEN1
SCHEMBL190585 0.68 ALDH1A1 (0.53) L3MBTL1ALDH1A1MAPK1HTT
SCHEMBL16507366 0.68 ALDH1A1 (0.53) L3MBTL1ALDH1A1MAPK1HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268634-A2 PROCESSES FOR THE PREPARATION OF BOSENTAN AND RELATED COMPOUNDS USING NOVEL INTERMEDIATES Actavis Group PTC EHF (IS) 2011-01-05 EP disclosed
WO-2009112954-A2 PROCESSES FOR THE PREPARATION OF BOSENTAN AND RELATED COMPOUNDS USING NOVEL INTERMEDIATES ACTAVIS GROUP PTC EHF (IS) 2009-09-17 WO disclosed